logo-loader

Proactive snapshot: Bluebird Merchant Ventures, Itaconix, Applied Graphene Materials

A glance at some of Tuesday's highlights from the Proactive Investors newswire

Greatland Gold PLC -

Greatland Gold PLC (LON:GGP) has reported what are described as "excellent" drill results from the Havieron project, in Western Australia, where work has been focussing on higher-grade zones.

ANGLE PLC’s (LON:AGL) Parsortix system has shown potential to outperform current standards of care for the detection and assessment of prostate cancer.

Bluebird Merchant Ventures Ltd (LON:BMV) has been granted the permit to develop the Gubong gold mine in South Korea. 

Futura Medical PLC (LON:FUM) has agreed a joint venture with cannabis firm CBDerma Technology Limited to develop a skin-friendly cannabidiol (CBD) formulation. The joint venture will explore combining CBD with Futura’s DermaSys drug delivery system for the treatment of such symptoms as pain relief.

Itaconix PLC (LON:ITX) posted a sharp rise in first-half profit and revenue as it completed a restructuring of the business and expanded into new markets.

Immotion Group PLC (LON:IMMO) has cited “encouraging” trading from partner sites over the summer as it continued its focus on high footfall locations.

Applied Graphene Materials (LON:AGM) will fly the flag for graphene at two major coatings conferences this week, after launching two unique epoxy adhesive systems for the space and defence sectors. 

Polarean Imaging PLC (LON:POLX) has delivered and installed its latest 9820 Xenon Polariser system at the Hospital for Sick Children in Toronto.

Enteq Upstream PLC (LON:NTQ) has taken out a licence from oil giant Royal Dutch Shell PLC (LON:RDSB) to use its intellectual property and other technology in a specialised rotary steerable drilling system.

Savannah Resources PLC (LON:SAV) has been conditionally awarded new mining concessions for the Mutamba project in Mozambique. The project is described as “one of the most significant undeveloped heavy mineral sands deposits in the world” and the new concessions span some 280 square kilometres.

Directa Plus PLC (LON:DCTA) has been awarded an Italian patent for a new textile membrane using its G+ graphene nanoplatelets.

Solo Oil PLC (LON:SOLO) told investors that it has exited its Nigerian marginal fields venture. The company has agreed to sell its 20% interest in Burj Petroleum Africa which previously applied for undeveloped Nigerian assets back in 2014. The stake is being sold for a nominal £1 to another shareholder in Burj.

ReNeuron Group PLC (AIM: RENE) said it remained in negotiations with potential partners for all of its key programmes. The company was providing an update on progress ahead of its annual meeting on Tuesday.

AdEPT Technology Group PLC (LON:ADT) is in “a position to grasp opportunities we couldn't have contemplated five years ago”, the company said in a letter to shareholders on Tuesday.

Providence Resources PLC (LON:PVR) told investors that the site survey for the first location has been completed as it updated on the continuing uncertainty over the APEC farm-out funds.

Tissue Regenix Group PLC (LON:TRX) said it was focused on initiatives to increase capacity and alleviate supply “constraints” as it continued to see strong demand for its products.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Greatland Gold PLC named herein, including the promotion by the Company of Greatland Gold PLC in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: CB2 Insights licenses electronic data capture software to UK...

CB2 Insights (CSE:CBII-OTCQB: CBIIF) CEO Prad Sekar joined Steve Darling from Proactive Vancouver to discuss the company doing a deal with MYACCESS Clinics. This will allow CB2’s software to capture comprehensive data sets related to patient health and treatment histories and manage ongoing...

1 day, 12 hours ago

3 min read